Qiubin preparation workshop stock busy
Release time:
2021-07-01
6# January 18 , there was a busy scene in the Qiubin preparation workshop of Jianfeng Pharmaceutical. On the eye drops production line, with the operation of the machine, the white bottles filled one by one are transported out and neatly arranged in the stainless steel frame, waiting to be sent to the next process; in the clean area, the employees "are fully armed " , paying close attention to the filling situation; packing, packing, coding ... In each production position, the employees perform their duties and are busy in an orderly manner.
In recent years, with the influence of various factors such as the aging of my country's population, lifestyle changes, increased work intensity, increased allergens, and improper eye use, the incidence of various eye diseases has increased year by year, and the market for ophthalmic drugs The growth is fast, and anti-allergic drugs and macular degeneration drugs are the fast-growing ophthalmic drugs. Spike Pharmaceutical's olopatadine hydrochloride eye drops is a drug for the treatment of allergic conjunctivitis. It is the first of its kind in China to pass the consistency evaluation and won the bid in the fourth batch of national drug centralized procurement in 2 this year. In the procurement cycle, medical institutions will give priority to the use of drugs selected in centralized procurement. 5 June, the new standard began to be implemented. According to the sales plan, Jianfeng Pharmaceutical adjusted the production arrangement scientifically and reasonably to ensure stable market supply.
According to Wang Xiizhong, director of Qiubin Preparation Workshop, the production of olopatadine eye drops takes about hours to complete a batch of production from the production preparation of raw and auxiliary materials to the packaging requirements. Under normal circumstances, it takes about 11 hours to complete a batch of production, plus equipment cleaning and sterilization. The preparation workshop started to produce two batches of olopatadine eye drops a day from 6 May 10 , and completed one cycle of production by 18 . The employees are divided into two shifts, one shift a day, working from 6 in the morning to the end of 3: 4 a.m. the next day. sometimes the clearance is slightly delayed. the first shift has just left work, and the second shift is already preparing for the production of the day.
In order to ensure the smooth progress of the production task, in addition to the personnel in the preparation workshop, the First Manufacturing Department adjusted the production arrangement of Jinxi Powder Injection Workshop, and the adjustment personnel came to support the production and packaging of eye drops first. In order to solve the problems in production in time, the team members of the first manufacturing department took turns on duty and worked overtime until early morning with the employees. Considering the busy production, it is early morning after work, moreover, some employees are far away from home. In order to ensure that employees have enough rest time, the First Manufacturing Department specially applied for two dormitories to work shifts. Because this rush is the first large-scale stock after olopatadine won the bid for centralized procurement, the leaders of the group company and the pharmaceutical company attach great importance to it and go to the production site many times to understand the situation and visit the overtime workers. Pharmaceutical companies have also given a lot of support for production deployment and other aspects.
In order to solve the imbalance of product output and production in each workshop, the First Manufacturing Department has organized mutual learning and training for employees in different workshops and positions in recent years, with the aim of adjusting each other when workshop production is tight or production plans are temporarily adjusted. Zheng Kunwu, manager of the first manufacturing department, said that according to the market situation of olopatadine eye drops, the first manufacturing department will consider updating some equipment to expand production capacity, improve work efficiency and reduce labor costs. At the same time, it will further strengthen the training of one person and multiple posts to ensure sufficient personnel in key positions. (Reporter Ni Yingzhen)
More information
In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)
2023
03-21
Company sends off retired employees
On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.
2023
03-04
On the first day of the new year, group leaders went to the grassroots level.
On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.
2023
02-17
Group Companies Commend 2022 Advanced
On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.
2023
01-29
Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce
On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.
2023
01-12
Peak Pharmaceutical Donates Epidemic Prevention Materials
Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.
2023
01-12